medigraphic.com
SPANISH

Revista de Endocrinología y Nutrición

ISSN 0188-9796 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number 4

<< Back

Rev Endocrinol Nutr 2013; 21 (4)

Late onset of congenital adrenal hyperplasia. A case report

Martínez-Borja LM, Vergara-López A, Guillén-González MÁ
Full text How to cite this article

Language: Spanish
References: 9
Page: 187-190
PDF size: 188.16 Kb.


Key words:

Congenital adrenal hyperplasia, hypercortisolism.

ABSTRACT

The congenital adrenal hyperplasia (CAH) comprises a group of autosomal recesive disorders caused by deficient adrenal corticosteriod biosynthesis. We present the case seventeen years old woman who started since her menarche with oligomenorrea to amenorrea evolution, four years later, accompanied by acne, hirsutism, red-purple striae and obesity. In his secondment hospital, based on a negative 1 mg dexamethasone suppression test and high serum levels of adrenocorticotropine, Cushing´s disease (CD) was suspected. Transesfenoidal resection of a pituitary microadenoma was made with resolution of the symptoms only for 11 months, when urine cortisol was found to be elevated over 100 µ/d, so that she was referred for recurrence. The 17-hydroxyprogesterone levels were reported in 430 ng/dL, so CAH and Pseudocushing was diagnosed with exclusion of CD. Dexamethasone treatment was started. The main cause of CAH is 21-hydroxylase deficiency, but different clinical variants are identified, as the non-classical variant. By definition, CAH and hypercortisolism are mutually exclusive conditions, so, in this patient with both manifestations, other causes as cortisone reductase are necessary to be considered. The CAH diagnosis could be difficult and requires the thorough evaluation of the adrenal function, which highlights the importance of this case.


REFERENCES

  1. Speiser P, Azziz R, Baskin L, Ghizzoni L, Hensle T, Merke D, Meyer-Bahlburg H, Miller W, Montori V, Oberfield S, Ritzen M et al: Congenital adrenal hiperplasia due to steroid 21-hydroxylase deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010; 95: 4133-4460.

  2. Speiser P, Dupont J, Zhud et al: Disease expression and molecular genotype in congenital adrenal hiperplasia due to 21-hydroxylase deficiency. J Clin Invest. 1992; 90: 584-595.

  3. Hye Jeong K, Mira K, Jae Hyeon K, Sun Wook K, Jae Hoon C, Yong-Ki M, Moon-Kyu L, Kwang-Won K, Myung-Shik L: A case of congenital adrenal hiperplasia mimicking Cushing’s syndrome. J Korean Med Sci. 2012; 27: 1439-1443.

  4. Seckl J, Walker B: Minireview: 11β-Hydroysteroid Dehydrogenase Type 1: a tissue-specific amplifier of glucocorticoid action. Endo. 2001; 142: 1371-1376.

  5. Jamieson A, Wallace B, Andrew R, Nunez S, Walker B, Fraser R, White C, Connell C: Apparent cortisone reductase deficiency: A functional defect in 11β-Hydroysteroid Dehydrogenase Type 1. J Clin Endocrinol Metab. 1999; 84: 3570-3574.

  6. Tomlinson J, Walker E, Bujalska I, Draper N, Lavery G, Cooper M, Hewison M, Stewart P: 11β-Hydroysteroid Dehydrogenase Type 1: a tissue-specific regulator of glucocorticoid responses. Endocrine Reviews. 2004; 25: 831-866.

  7. Stinson R, Anderson J, Andrew R, Redhead D, Karpe F, Hayes P, Olsson T, Walker B: Cortisol release from adipose tissue by 11β-Hydroysteroid Dehydrogenase Type 1 in humans. Diabetes. 2009; 58: 46-53.

  8. Auchus RJ, Arlt W: Approach to the patient: the adult with congenital adrenal hiperplasia. Clin Endocrinol metab. 2013; 98: 2645-2655.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Endocrinol Nutr. 2013;21